Genelux Corporation
GNLX institutional ownership changes in Q2 2026: 16 institutions opened or added positions, 17 trimmed or exited. GNLX (Genelux Corporation) is held by 37 institutional investors as of Q2 2026. Top institutional shareholders: Vanguard Capital Management LLC ($5M), BlackRock, Inc. ($1.3M), Geode Capital Management, LLC ($1.3M). Institutions were selling, on balance.
Who's Trading
Latest move
Source dates: Price Nov 6, 2026 · Insiders Nov 5, 2026 · Activists Nov 4, 2026 · Congress none
Top Holders
| Action | ||||||
|---|---|---|---|---|---|---|
Decreased | 1.7M(-1.1%) | $5M | 0.0% | -20.66% | 0 | |
Increased | 439,602(+8.3%) | $1.3M | 0.0% | -28.26% | 19 | |
Decreased | 439,213(-3.2%) | $1.3M | 0.0% | -85.26% | 0 | |
Increased | 328,803(+1.5%) | $989,697 | 0.0% | -46.03% | 25 | |
Decreased | 236,344(-6.1%) | $711,395 | 0.0% | -20.66% | 0 | |
Increased | 157,857(+13.5%) | $475,150 | 0.0% | -73.73% | 27 | |
Unchanged | 145,850 | $439,009 | 0.0% | -83.63% | 0 | |
Increased | 121,958(+2.5%) | $367,091 | 0.0% | -34.60% | 24 | |
Increased | 105,229(+762.5%) | $316,739 | 0.0% | -38.74% | 38 | |
Decreased | 89,279(-45.7%) | $268,730 | 0.0% | -80.63% | 0 | |
New | 85,481 | $257,298 | 0.0% | -36.21% | 35 | |
Decreased | 83,543(-5.1%) | $251,464 | 0.0% | -37.33% | 0 | |
Increased | 52,866(+89.7%) | $159,127 | 0.0% | -28.86% | 35 | |
New | 45,881 | $138,102 | 0.0% | -36.21% | 31 | |
Increased | 45,809(+40.5%) | $137,885 | 0.0% | -50.30% | 20 | |
Decreased | 44,794(-1.7%) | $134,830 | 0.0% | +22.27% | 0 | |
Unchanged | 41,000 | $124,230 | 0.0% | -27.83% | 0 | |
Increased | 39,539(+72.4%) | $119,012 | 0.0% | -49.38% | 33 | |
Decreased | 34,995(-71.5%) | $105,335 | 0.0% | -44.00% | 0 | |
Increased | 33,379(+148.2%) | $100,000 | 0.0% | -30.74% | 35 |
Showing 1-20 of 41
| Insider | Trade | Traded |
|---|---|---|
| Cappello Joseph | Sell $1K | |
| Zindrick Thomas | Sell $6K | |
| Yu Yong | Sell $1K | |
| Cappello Joseph | Sell $28K | |
| Zindrick Thomas | Sell $92K | |
| Yu Yong | Sell $27K | |
| Yu Yong | Sell $2K | |
| Zindrick Thomas | Sell $9K | |
| Cappello Joseph | Sell $2K | |
| Smither John W | Sell $35K |
| Filer | Stake | Filed |
|---|---|---|
| Aladar Szalay | 6.2% | |
| Aladar Szalay | 8.2% | |
| Armistice Capital, LLC | 10.0% |
GNLXGenelux CorporationContinue exploring
Other Healthcare stocks held by institutions
UNHUnitedHealth Group Incorporated
LLYEli Lilly and Company
TMOThermo Fisher Scientific Inc
JNJJohnson & Johnson
DHRDanaher Corporation
ISRGIntuitive Surgical, Inc.
MRKMerck & Company, Inc.
ABBVAbbVie Inc.
BSXBoston Scientific Corporation
ABTAbbott LaboratoriesQuestions investors ask about GNLX
Who owns GNLX?
37 institutional investors held GNLX on June 30, 2026, led by Vanguard Capital Management LLC ($5M), BlackRock, Inc. ($1.3M) and Geode Capital Management, LLC ($1.3M).
How many hedge funds hold GNLX?
37 institutional investors reported GNLX in their 13F filings for the quarter ended June 30, 2026, $13.4M in all. One of them is rated Elite.
Are institutions buying or selling GNLX?
Selling, on balance. In Q2 2026, 17 institutions trimmed or exited GNLX and 16 institutions opened or added to positions.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer